CoChat

Increased afterload induces pathological cardiac hypertrophy: a new in vitro model

Open access
Hirt, Marc N., Sörensen, Nils A., Bartholdt, Lena M., Boeddinghaus, Jasper, Schaaf, Sebastian, Eder, Alexandra, Vollert, Ingra, Stöhr, Andrea, Schulze, Thomas, Witten, Anika, Stoll, Monika, Hansen, Arne, Eschenhagen, Thomas · 2012 · Basic Research in Cardiology

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Increased afterload results in 'pathological' cardiac hypertrophy, the most important risk factor for the development of heart failure. Current in vitro models fall short in deciphering the mechanisms of hypertrophy induced by afterload enhancement. The aim of this study was to develop an experimental model that allows investigating the impact of afterload enhancement (AE) on work-performing heart muscles in vitro. Fibrin-based engineered heart tissue (EHT) was cast between two hollow elastic silicone posts in a 24-well cell culture format. After 2 weeks, the posts were reinforced with metal braces, which markedly increased afterload of the spontaneously beating EHTs. Serum-free, triiodothyronine-, and hydrocortisone-supplemented medium conditions were established to prevent undefined serum effects. Control EHTs were handled identically without reinforcement. Endothelin-1 (ET-1)- or phenylephrine (PE)-stimulated EHTs served as positive control for hypertrophy. Cardiomyocytes in EHTs enlarged by 28.4 % under AE and to a similar extent by ET-1- or PE-stimulation (40.6 or 23.6 %), as determined by dystrophin staining. Cardiomyocyte hypertrophy was accompanied by activation of the fetal gene program, increased glucose consumption, and increased mRNA levels and extracellular deposition of collagen-1. Importantly, afterload-enhanced EHTs exhibited reduced contractile force and impaired diastolic relaxation directly after release of the metal braces. These deleterious effects of afterload enhancement were preventable by endothelin-A, but not endothelin-B receptor blockade. Sustained afterload enhancement of EHTs alone is sufficient to induce pathological cardiac remodeling with reduced contractile function and increased glucose consumption. The model will be useful to investigate novel therapeutic approaches in a simple and fast manner.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00395-012-0307-z

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Formulation of serum-free EHT medium by T 3 supplementation, experimental model of afterload enhancement. a 20 EHTs were cultured in identical medium for 13 days. Reduction of horse serum content on day 8 did not affect their development. From day 13 on EHTs were kept in medium free of horse serum, but in addition with varying T 3 concentrations. Without T 3 EHTs completely stopped to beat after 2 days (dashed line). Addition of T 3 in a range of 0.5 to 5.0 ng/mL prevented the decline in force. b–d Microscopic images of an EHT cultured 8 days in horse-serum free and T 3 0.5 ng/mL supplemented medium. b H&E-stained paraffin section. c Merged confocal analysis of an area close to the surface of an EHT stained with an antibody against α-actinin (cyan) and with DRAQ5 (yellow). d Electron microscopy. Despite absence of serum for more than a week, there was a well-developed cardiac tissue structure with longitudinal alignment of cells and distinct ultrastructure of sarcomers with Z, I, A, H, and infrequently M-bands (arrow). Fi fibrin, Mi mitochondrion, Co collagen, ID part of an intercalated disc with desmosomes, S sarcomere, M M-Band. e Photograph of insertion of metal braces. EHTs and silicone racks were taken out of medium and cell culture dish only for better depiction, scale in millimeters. For histological or biomolecular analyses only the middle sections (between the broken lines) of EHTs were analyzed
Fig. 1 Formulation of serum-free EHT medium by T 3 supplementation, experimental model of afterload enhancement. a 20 EHTs were cultured in identical medium for 13 days. Reduction of horse serum content on day 8 did not affect their development. From day 13 on EHTs were kept in medium free of horse serum, but in addition with varying T 3 concentrations. Without T 3 EHTs completely stopped to beat after 2 days (dashed line). Addition of T 3 in a range of 0.5 to 5.0 ng/mL prevented the decline in force. b–d Microscopic images of an EHT cultured 8 days in horse-serum free and T 3 0.5 ng/mL supplemented medium. b H&E-stained paraffin section. c Merged confocal analysis of an area close to the surface of an EHT stained with an antibody against α-actinin (cyan) and with DRAQ5 (yellow). d Electron microscopy. Despite absence of serum for more than a week, there was a well-developed cardiac tissue structure with longitudinal alignment of cells and distinct ultrastructure of sarcomers with Z, I, A, H, and infrequently M-bands (arrow). Fi fibrin, Mi mitochondrion, Co collagen, ID part of an intercalated disc with desmosomes, S sarcomere, M M-Band. e Photograph of insertion of metal braces. EHTs and silicone racks were taken out of medium and cell culture dish only for better depiction, scale in millimeters. For histological or biomolecular analyses only the middle sections (between the broken lines) of EHTs were analyzedCC BY · PubMed Central
Fig. 2 Activation of the hypertrophic gene program. a Transcript concentrations of members of the hypertrophic program as measured by RT-qPCR. All concentrations were normalized to controls. (n = 3–6 biological × 3 technical replicates). b Western blot analysis of EHTs (100,000 cells per lane) for β-MHC. The total amount of ERK 1/2 served as loading control. c Validation of ANP-immunohistochemistry on healthy adult rat heart. The characteristic perinuclear staining pattern for ANP could be detected in the atrium, whereas little ANP was detectable in the ventricle. d ANP-immunohistochemistry of EHTs. In control EHTs only very few cells at the surface stained positive for ANP. All EHTs subjected to hypertrophic interventions showed stronger ANP signals which were also perinuclearly located. The images cover more than one half of the EHT diameter (see pictograph) and were taken from the same area of the respective EHT
Fig. 2 Activation of the hypertrophic gene program. a Transcript concentrations of members of the hypertrophic program as measured by RT-qPCR. All concentrations were normalized to controls. (n = 3–6 biological × 3 technical replicates). b Western blot analysis of EHTs (100,000 cells per lane) for β-MHC. The total amount of ERK 1/2 served as loading control. c Validation of ANP-immunohistochemistry on healthy adult rat heart. The characteristic perinuclear staining pattern for ANP could be detected in the atrium, whereas little ANP was detectable in the ventricle. d ANP-immunohistochemistry of EHTs. In control EHTs only very few cells at the surface stained positive for ANP. All EHTs subjected to hypertrophic interventions showed stronger ANP signals which were also perinuclearly located. The images cover more than one half of the EHT diameter (see pictograph) and were taken from the same area of the respective EHTCC BY · PubMed Central
Fig. 3 Specific cardiomyocyte cell membrane staining and in situ assessment of average cardiomyocyte size in EHTs. a Validation of dystrophin-immunohistochemistry on healthy adult rat heart. b Dystrophin-immunohistochemistry of an EHT cross section. Only cell membranes of cardiomyocytes were stained brown and thus distinguishable from other cell types. c Assessment of cross-sectional areas of 150 cardiomyocytes per group, three EHTs were analyzed per group. In control EHTs cardiomyocytes had a mean cross-sectional area of 62.3 μm2, after hypertrophic interventions mean sizes were 80.0 μm2 (afterload enhanced), 87.6 μm2 (ET-1-stimulated), and 77.0 μm2 (PE-stimulated). d Box-and-whisker diagram of cross-sectional area measurements. Whiskers represent percentile 2.5 and 97.5, dots display extreme values
Fig. 3 Specific cardiomyocyte cell membrane staining and in situ assessment of average cardiomyocyte size in EHTs. a Validation of dystrophin-immunohistochemistry on healthy adult rat heart. b Dystrophin-immunohistochemistry of an EHT cross section. Only cell membranes of cardiomyocytes were stained brown and thus distinguishable from other cell types. c Assessment of cross-sectional areas of 150 cardiomyocytes per group, three EHTs were analyzed per group. In control EHTs cardiomyocytes had a mean cross-sectional area of 62.3 μm2, after hypertrophic interventions mean sizes were 80.0 μm2 (afterload enhanced), 87.6 μm2 (ET-1-stimulated), and 77.0 μm2 (PE-stimulated). d Box-and-whisker diagram of cross-sectional area measurements. Whiskers represent percentile 2.5 and 97.5, dots display extreme valuesCC BY · PubMed Central
Fig. 4 Gene expression analysis. a Software-aided clustering of 24 EHTs according to their concordance of gene expression. Input data was a whole transcriptome analysis (21,910 probes) for all EHTs. EHTs in the control group (n = 6 biological replicates, above the thick line) and in the groups with hypertrophic interventions (n = 18 biological replicates, below the thick line) were all classified correctly. Asterisks denote pairs of technical replicates. b–c Comparison of genes upregulated by afterload enhancement in EHTs (Rat AE-EHTs) with genes upregulated by TAC in mice. Mouse TAC I and II data sets were both taken from the literature. The latter data set was provided for two time points: short-term TAC (1 week, displayed in b, d) and long-term TAC (8 weeks, displayed in c, e). d–e Corresponding diagrams for downregulated genes in AE-EHTs and TAC. Note that Serca2a (Atp2a2) downregulation was falsely not detected by our rat microarray but by RT-qPCR. Its corrected positions are indicated with asterisks
Fig. 4 Gene expression analysis. a Software-aided clustering of 24 EHTs according to their concordance of gene expression. Input data was a whole transcriptome analysis (21,910 probes) for all EHTs. EHTs in the control group (n = 6 biological replicates, above the thick line) and in the groups with hypertrophic interventions (n = 18 biological replicates, below the thick line) were all classified correctly. Asterisks denote pairs of technical replicates. b–c Comparison of genes upregulated by afterload enhancement in EHTs (Rat AE-EHTs) with genes upregulated by TAC in mice. Mouse TAC I and II data sets were both taken from the literature. The latter data set was provided for two time points: short-term TAC (1 week, displayed in b, d) and long-term TAC (8 weeks, displayed in c, e). d–e Corresponding diagrams for downregulated genes in AE-EHTs and TAC. Note that Serca2a (Atp2a2) downregulation was falsely not detected by our rat microarray but by RT-qPCR. Its corrected positions are indicated with asterisksCC BY · PubMed Central
Fig. 5 Glucose consumption. a Global glucose consumption of EHTs under control or hypertrophic conditions. b Glucose consumption correlated to some extent with beating rate of EHTs. The regression line of AE is shifted in y-direction compared to the regression line of control. Each point represents one EHT. c Spontaneous beating rate of control and hypertrophied EHTs. d Glucose consumption per beat as determined by dividing global glucose consumption by the calculated total number of beats over the observation period. (all n = 7–9 per group)
Fig. 5 Glucose consumption. a Global glucose consumption of EHTs under control or hypertrophic conditions. b Glucose consumption correlated to some extent with beating rate of EHTs. The regression line of AE is shifted in y-direction compared to the regression line of control. Each point represents one EHT. c Spontaneous beating rate of control and hypertrophied EHTs. d Glucose consumption per beat as determined by dividing global glucose consumption by the calculated total number of beats over the observation period. (all n = 7–9 per group)CC BY · PubMed Central
Fig. 6 Collagen-1-immunohistochemistry as an indicator of fibrosis. a Validation of collagen-1-immunohistochemistry on paraffin sections of healthy adult rat heart. Collagen-1 was interspersed between cardiomyocytes and dominant in epicardium. b Low basal collagen-1 content in control EHTs in contrast to c–e interspersion with collagen-1 after hypertrophic interventions (all in longitudinal orientation). f Higher magnification of an afterload enhanced EHT. Fibrillar Collagen-1 protruded from cardiac fibroblasts and adsorbed onto cardiomyocytes
Fig. 6 Collagen-1-immunohistochemistry as an indicator of fibrosis. a Validation of collagen-1-immunohistochemistry on paraffin sections of healthy adult rat heart. Collagen-1 was interspersed between cardiomyocytes and dominant in epicardium. b Low basal collagen-1 content in control EHTs in contrast to c–e interspersion with collagen-1 after hypertrophic interventions (all in longitudinal orientation). f Higher magnification of an afterload enhanced EHT. Fibrillar Collagen-1 protruded from cardiac fibroblasts and adsorbed onto cardiomyocytesCC BY · PubMed Central
Fig. 7 Functional consequences of hypertrophic interventions on EHTs. a Example of a video-optical recording of an EHT. Blue squares in the still image (above) indicate positions which are used to analyze EHT contractions. The corresponding contraction recording over a period of 10 s is depicted below. b Pictograph of one contraction peak and the values derived from it. Note that T 1 and T 2 are measured from or to the time of 50 % of maximum contraction. c–g Functional parameters of hypertrophied EHTs after removal of the metal braces in comparison to control EHTs. c Force of contraction. d Maximum contraction velocity. e Maximum relaxation velocity. f Contraction time T 1. g Relaxation time T 2. (all n = 8–9 per group)
Fig. 7 Functional consequences of hypertrophic interventions on EHTs. a Example of a video-optical recording of an EHT. Blue squares in the still image (above) indicate positions which are used to analyze EHT contractions. The corresponding contraction recording over a period of 10 s is depicted below. b Pictograph of one contraction peak and the values derived from it. Note that T 1 and T 2 are measured from or to the time of 50 % of maximum contraction. c–g Functional parameters of hypertrophied EHTs after removal of the metal braces in comparison to control EHTs. c Force of contraction. d Maximum contraction velocity. e Maximum relaxation velocity. f Contraction time T 1. g Relaxation time T 2. (all n = 8–9 per group)CC BY · PubMed Central
Fig. 8 Prevention of the deleterious afterload enhancement effects by endothelin receptor blockade. a Transcript concentrations of members of the hypertrophic program as measured by RT-qPCR. Concentrations of AE-EHTs and AE-EHTs under blockade with the combined ETA/B-receptor antagonist (ETA/B-RA) PD 142893 were normalized to controls. (n = 5 biological × 3 technical replicates). b Collagen-1-immunohistochemistry as an indicator of fibrosis in control, AE-EHTs and EHT under ETA/B-receptor blockade. c Force and d relaxation time T2 of EHTs after removal of the metal braces in comparison to control EHTs. AE + ETA/B-RA were blocked with the combined ETA/B-RA PD 142893, whereas ETA-RA stands for selective ETA-blockade with BQ-123 and ETB for selective ETB-blockade with BQ-788. (n = 10–15 per group)
Fig. 8 Prevention of the deleterious afterload enhancement effects by endothelin receptor blockade. a Transcript concentrations of members of the hypertrophic program as measured by RT-qPCR. Concentrations of AE-EHTs and AE-EHTs under blockade with the combined ETA/B-receptor antagonist (ETA/B-RA) PD 142893 were normalized to controls. (n = 5 biological × 3 technical replicates). b Collagen-1-immunohistochemistry as an indicator of fibrosis in control, AE-EHTs and EHT under ETA/B-receptor blockade. c Force and d relaxation time T2 of EHTs after removal of the metal braces in comparison to control EHTs. AE + ETA/B-RA were blocked with the combined ETA/B-RA PD 142893, whereas ETA-RA stands for selective ETA-blockade with BQ-123 and ETB for selective ETB-blockade with BQ-788. (n = 10–15 per group)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 45 references

Cited by

See all 154

Metadata

Authors
Hirt, M. N., Sörensen, N. A., Bartholdt, L. M., Boeddinghaus, J., Schaaf, S., Eder, A., Vollert, I., Stöhr, A., Schulze, T., Witten, A., Stoll, M., Hansen, A., & Eschenhagen, T.
Affiliations
University Medical Center Hamburg-Eppendorf (DE)
Venue
Basic Research in Cardiology
Published
2012-10-26
Volume
107
Issue
6
Pages
307-307
ISSN
  • 0003-9217 (ISSN-L)
  • 0300-8428
  • 1435-1803
OpenAlex
W2024763420
Cited by
154
References
45
Citations by year
2026: 5 · 2025: 6 · 2024: 5 · 2023: 7 · 2022: 14 · 2021: 19 · 2020: 14 · 2019: 15 · 2018: 17 · 2017: 10 · 2016: 13 · 2015: 11 · 2014: 11 · 2013: 7
FWCI
5.97
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Basic Research in Cardiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • European Commission
  • Deutsche Forschungsgemeinschaft (HA 3423/3-1, Es 88/12-1, 88/12-1)
  • Deutsche Herzstiftung (F/13/10)
  • Leibniz-Gemeinschaft
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords
pathological cardiac hypertrophy, engineered heart tissue, in vitro model, cardiomyocyte hypertrophy, endothelin-1, ETA receptor, endothelin B receptor, phenylephrine, fetal gene program, collagen deposition, glucose utilization, contractile force, diastolic relaxation, heart failure, cardiac remodeling
MeSH terms
Animals, Animals, Newborn, Cells, Cultured, Fibrosis, Glycolysis, Cardiomegaly, Models, Biological, Rats, Inbred Lew, Gene Expression, Rats, Wistar, Tissue Engineering, Myocytes, Cardiac, Rats, Endothelin Receptor Antagonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. https://app.cochat.ai/papers/10.1007/s00395-012-0307-z
The paper
Hirt, M. N., Sörensen, N. A., Bartholdt, L. M., Boeddinghaus, J., Schaaf, S., Eder, A., Vollert, I., Stöhr, A., Schulze, T., Witten, A., Stoll, M., Hansen, A., & Eschenhagen, T. (2012). Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic Research in Cardiology. https://doi.org/10.1007/s00395-012-0307-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.